Oxime ethers as IIb/IIa antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6348504
SERIAL NO

09282037

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

##STR1## This invention relates generally to oxime ethers which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DUPONT PHARMACEUTICALS COMPANYLEGAL DIVISION CHESTNUT RUN PLAZA 974 CENTRE ROAD WILMINGTON DE 19805

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frietze, William E 900 Merrybelle La., Kennett Square, PA 19348 4 13
Olson, Richard E 600 Silverside Rd., Wilmington, DE 19809 142 1446

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation